18.64
Si Bone Inc stock is traded at $18.64, with a volume of 204.49K.
It is down -1.37% in the last 24 hours and up +7.43% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$18.93
Open:
$18.82
24h Volume:
204.49K
Relative Volume:
0.37
Market Cap:
$835.42M
Revenue:
$206.22M
Net Income/Loss:
$-16.70M
P/E Ratio:
-48.30
EPS:
-0.386
Net Cash Flow:
$-5.55M
1W Performance:
-0.90%
1M Performance:
+7.43%
6M Performance:
+22.43%
1Y Performance:
+20.77%
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SIBN
Si Bone Inc
|
18.64 | 848.42M | 206.22M | -16.70M | -5.55M | -0.386 |
|
ABT
Abbott Laboratories
|
110.09 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
332.01 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.64 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.53 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.79 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Cadian Capital discloses 7.5% SI-BONE (SIBN) ownership in Schedule 13G filing - Stock Titan
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript - AOL.com
(SIBN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
SI-BONE (STU:2K3) Shiller PE Ratio : (As of Aug. 12, 2026) - GuruFocus
SI-BONE (STU:2K3) Cyclically Adjusted Price-to-FCF : (As of Aug. 12, 2026) - GuruFocus
SI-BONE Inc (STU:2K3) Stock News, Headlines & Updates - GuruFocus
Who's Buying or Selling SI-BONE Inc (STU:2K3) Stock Today? - GuruFocus
SI-BONE Inc Stock Baskets - GuruFocus
SI-BONE Inc (STU:2K3) Stock Earnings Transcripts - GuruFocus
SI-BONE Inc (STU:2K3) Stock Price & 30 Year Financial Data - GuruFocus
SI-BONE Inc Stock Operating Data - GuruFocus
SiBone $SIBN Shares Bought by Dimensional Fund Advisors LP - marketbeat.com
SI-BONE Inc (SIBN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SiBone (NASDAQ:SIBN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
The SI-BONE, Inc. (NASDAQ:SIBN) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 37.82% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
SiBone $SIBN Shares Purchased by Sei Investments Co. - MarketBeat
Renaissance Technologies LLC Increases Stake in SiBone $SIBN - marketbeat.com
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $20 to $27 - Moomoo
BlackRock, Inc. Adds to SI-BONE Inc (SIBN) Stake -- Shares Trade 13% Below GF Value - GuruFocus
SI-BONE, Inc. (SIBN) director sells 20,000 shares after option exercise - Stock Titan
Canaccord reiterates SI-BONE stock rating on strong Q2 results By Investing.com - Investing.com India
SIBN Maintained by UBS -- Price Target Raised to $25 - GuruFocus
SI BONE : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
SI-BONE, Inc. 2026: Revenue $56.01M, EPS ($0.09) — 10-Q Summary - TradingView
SIBN Maintained by TD Cowen -- Price Target Raised to $20.00 - GuruFocus
SiBone's (SIBN) Buy Rating Reaffirmed at Truist Financial - marketbeat.com
UBS Lifts Price Target on SI-BONE to $25 From $24, Maintains Buy Rating - marketscreener.com
SI-BONE, Inc. Stock 12‑Month Price Target Raised to $25, Implies 36% Upside - TradingView
Canaccord reiterates SI-BONE stock rating on strong Q2 results - Investing.com Nigeria
SI-BONE, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Truist Adjusts Price Target on SI-BONE to $23 From $21, Maintains Buy Rating - marketscreener.com
SIBN Looks 10.6% Undervalued on GF Value™ Amid Strong Growth Pro - GuruFocus
SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Re - GuruFocus
SIBN Looks 10.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Earnings call transcript: SI-BONE tops Q2 2026 estimates, shares fall after hours - Investing.com Nigeria
SIBN Q2 FY2026 earnings call - finance.biggo.com
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance Singapore
SiBone Q2 Earnings Call Highlights - MarketBeat
Earnings Flash (SIBN) SI-BONE Posts Q2 Loss $0.09 per Share, vs. FactSet Est of $0.15 Loss - marketscreener.com
SI-BONE Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (SIBN) SI-BONE, Inc. Reports Q2 Revenue $56.0M, vs. FactSet Est of $55.3M - marketscreener.com
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance - The Manila Times
SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook - TradingView
SI-BONE Reports Q2 2026: $56.0M Revenue, Positive Adjusted EBITDA of $2.8M, Raises 2026 Revenue Guidance - TradingView
BRIEF-SI-BONE Q2 Revenue USD 56.01 Million Vs. IBES Estimate USD 55.3 Million - TradingView
SiBone (SIBN) Earnings Date and Reports 2026 - marketbeat.com
SI-BONE Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
BlackRock, Inc. (SIBN) discloses 3.56M-share, 8% passive stake in SI-BONE - Stock Titan
SiBone (NASDAQ:SIBN) Rating Increased to Strong-Buy at UBS Group - MarketBeat
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Si Bone Inc Stock (SIBN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | Director |
Aug 03 '26 |
Sale |
18.46 |
20,000 |
369,214 |
16,057 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):